Bank of New York Mellon Corp - NEWLINK GENETICS CORP ownership

NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 86 filers reported holding NEWLINK GENETICS CORP in Q4 2013. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of NEWLINK GENETICS CORP
ValueSharesWeighting
Q4 2019$181,000
+58.8%
71,5400.0%0.00%
Q3 2019$114,000
+60.6%
71,540
+48.2%
0.00%
Q2 2019$71,000
-74.5%
48,280
-66.5%
0.00%
Q1 2019$278,000
+25.2%
144,195
-1.1%
0.00%
Q4 2018$222,000
-23.2%
145,832
+20.8%
0.00%
Q3 2018$289,000
-51.0%
120,748
-2.6%
0.00%
Q2 2018$590,000
-34.7%
123,913
-0.5%
0.00%
Q1 2018$903,000
-4.9%
124,484
+6.2%
0.00%
Q4 2017$950,000
-10.3%
117,179
+12.7%
0.00%
Q3 2017$1,059,000
+38.1%
103,975
-0.4%
0.00%
Q2 2017$767,000
-84.3%
104,384
-48.5%
0.00%
-100.0%
Q1 2017$4,881,000
+274.3%
202,540
+59.6%
0.00%
Q4 2016$1,304,000
-40.9%
126,930
-13.6%
0.00%
-100.0%
Q3 2016$2,206,000
+32.6%
146,857
-0.6%
0.00%0.0%
Q2 2016$1,664,000
-36.9%
147,733
+2.0%
0.00%0.0%
Q1 2016$2,636,000
-51.5%
144,841
-2.9%
0.00%
-50.0%
Q4 2015$5,430,000
+37.5%
149,226
+35.4%
0.00%
+100.0%
Q3 2015$3,949,000
-30.0%
110,197
-13.5%
0.00%
-50.0%
Q2 2015$5,642,000
-13.6%
127,446
+6.8%
0.00%0.0%
Q1 2015$6,530,000
+47.4%
119,370
+7.1%
0.00%
+100.0%
Q4 2014$4,429,000
+87.9%
111,418
+1.3%
0.00%0.0%
Q3 2014$2,357,000
-54.8%
110,000
-44.0%
0.00%0.0%
Q2 2014$5,218,000
+74.3%
196,572
+86.5%
0.00%0.0%
Q1 2014$2,994,000
+61.0%
105,423
+24.7%
0.00%0.0%
Q4 2013$1,860,000
-37.1%
84,510
-46.3%
0.00%
Q3 2013$2,956,000
+95.9%
157,374
+105.6%
0.00%
Q2 2013$1,509,00076,5330.00%
Other shareholders
NEWLINK GENETICS CORP shareholders Q4 2013
NameSharesValueWeighting ↓
FT Options LLC 21,900$1,292,0001.11%
TIVERTON ASSET MANAGEMENT LLC 288,807$18,215,0000.77%
Knoll Capital Management, LLC 102,437$1,153,0000.37%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 460,146$5,181,0000.36%
WALL STREET ASSOCIATES 79,000$890,0000.36%
Endurant Capital Management LP 62,491$704,0000.24%
FT Options LLC 21,903$247,0000.21%
Virtus ETF Advisers LLC 24,463$275,0000.20%
Orbimed Advisors 1,581,506$17,808,0000.19%
HAP Trading, LLC 227,728$2,564,0000.15%
View complete list of NEWLINK GENETICS CORP shareholders